Coronavirus Disease-2019 and Mental Health by Darmadi, Darmadi & Ruslie, Riska Habriel
268 https://www.id-press.eu/mjms/index
Scientific Foundation SPIROSKI, Skopje, Republic of Macedonia
Open Access Macedonian Journal of Medical Sciences. 2020 Oct 05; 8(T1):268-271.
https://doi.org/10.3889/oamjms.2020.5304
eISSN: 1857-9655
Category: T1 - Thematic Issue “Coronavirus Disease (COVID-19)”
Section: Psychiatry
Coronavirus Disease-2019 and Mental Health
Riska Habriel Ruslie1, Darmadi Darmadi2*
1Department of Child Health, Faculty of Medicine, Universitas Prima Indonesia, Medan, Indonesia; 2Department of Internal 
Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
Abstract
BACKGROUND: Coronavirus disease-2019 (COVID-19) emerges in Wuhan, China and becomes a pandemic 
on March 2020. Its manifestations mainly cover respiratory and gastrointestinal symptoms. In fact, mental health 
disorders are common in patients with COVID-19 but receive minimum attention. 
AIM: We aimed to discuss mental health disturbances in relation to COVID-19 and its management. 
MATERIALS AND METHODS: We gathered literature regarding the topic from electronic sources, including PubMed 
and Google Scholar. 
RESULTS: There are several pathogeneses proposed regarding the incidence of mental health problems. The 
symptoms of mental health problems vary widely and also affect health-care personnel. Diagnosing mental health 
problem in COVID-19 patients is quite difficult because no examinations are specific enough. The management of 
mental health problems includes psychological and medical managements. 
CONCLUSION: Further study regarding mental health problem and its management in patients with COVID-19 is 
mandatory.
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Introduction
Emerging in Wuhan, China in the end of 2019, 
coronavirus disease-2019 (COVID-19) has spread 
throughout the globe and caused significant morbidity 
and mortality [1], [2]. The World Health Organization 
had finally declared COVID-19 as a pandemic on 
March 11, 2020 [3]. There are many manifestations of 
COVID-19, including respiratory and gastrointestinal 
symptoms, but only a little attention is paid for mental 
health problem [1], [3], [4]. Before this COVID-19 
pandemic, other coronaviruses had already caused an 
epidemic which is a severe acute respiratory syndrome 
(SARS) in 2002 and Middle East respiratory syndrome 
(MERS) in 2012 [4]. Previous coronavirus epidemics 
also triggered mental health problems. The deficit 
in neuropsychiatry was reported to be present until 
18 months post-discharge [5]. During the previous 
SARS epidemic, 59% of SARS survivors suffered from 
psychiatric disorders in the first 3 years [1].
This COVID-19 pandemic is different with 
other disasters such as earthquake or tsunami. This 
pandemic showed no sign of ending. Besides, this 
pandemic affects everyone in every moment and every 
place. This causes a big uncertainty in one’s mind 
and leads to the mental problem [6]. It is important to 
note that mental health disturbance can cause more 
significant effects than the virus itself [7]. Several 
literatures had described mental health problems 
in association with COVID-19. A patient with 
COVID-19 was suffering from meningoencephalitis, 
marked by neck stiffness and transient generalized 
seizure [1]. Another study reported that 31% of patients 
with COVID-19 had altered mental status. Mental 
health problems seem to occur more often in younger 
patients [2]. Beach et al. reported 4 case series of 
COVID-19 patients with delirium [8]. There was also 
a positive association observed between coronavirus 
seropositivity and mood disorders [1]. A study from 
Egypt reported a significant psychological impact in 
the public from COVID-19 pandemic with depression 
as the most frequent, followed by anxiety [9].
Methods
We gathered literature regarding the topics 
from electronic sources, including PubMed and Google 
Scholar. We used “coronavirus,” “coronavirus disease 
2019,” “COVIC-19,” “mental,” “health,” “disorder,” and 
“disturbance” as the keywords in the search engine. We 
included literature published from December 2019 and 
on. All literatures were written in English.
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Pathogenesis of mental health disturbance 
in COVID-19
Coronavirus is a single-stranded ribonucleic 
acid virus with four major genera: Alphacoronavirus, 
betacoronavirus, gammacoronavirus, and 
deltacoronavirus. Previous epidemics, SARS-CoV, 
and MERS-CoV, together with SARS-CoV-2, belong 
to betacoronavirus genera [1], [4], [10]. SARS-CoV-2 
particles are detected in patients with multiple sclerosis 
giving a higher possibility of the virus neurotropism [1]. 
In vitro study had shown that SARS-CoV-2 can replicate 
in neurons [4], [5].
SARS-CoV-2 is hypothesized to enter the brain 
through the olfactory bud, resulting in rapid invasion with 
transneuronal spread and minimal cellular infiltration. 
This explains the presence of anosmia in patients with 
COVID-19 [1], [5], [8], [10], [11]. Viral invasion may occur 
through binding of virus with angiotensin-converting 
enzyme 2, which expressed in neurons, capillary, and 
neuronal endothelium. After invasion, the virus will trigger 
an inflammatory reaction, create cytokine storm [4], [5], 
[8], [10], [11], and lead to neuropsychiatric symptoms. 
Invasion into postrema increases the vulnerability of 
subjects toward depression and delirium [1], [5], [12]. 
Virus-induced central nervous system demyelination 
also occurs. Demyelination occurs due to an 
inflammatory reaction from molecular mimicry between 
coronavirus envelope S glycoproteins and myelin [1], 
[5], [12]. Other causes of mental disorders, including 
secondary to multiorgan failure, hypoxia, and treatment-
related [4], [8], [11], [12]. In addition, possible medullary 
neurons destruction after viral invasion may precipitate 
respiratory symptoms and cause acute respiratory 
distress [5], [8], [11]. Stress activates hypothalamus-
pituitary-adrenal axis and impairs immune system which 
further hampers the clinical condition [11].
In this modern era, every subject has the 
capability to travel and communicate widely. At present, 
these freedoms are restricted significantly due to 
COVID-19 [3], [13]. This condition affects both healthy 
and infected population [4] and leads to frustration and 
mental problems [3], [4], [5], [11], [13]. Hospitalization and 
uncertain prognosis of COVID-19 also clearly worsen 
the mental disorders [1], [5], [13]. Adverse events from 
medications used in COVID-19 contribute to mental 
health status such as insomnia from corticosteroid 
and psychotic disorder from chloroquine [1], [5], [11]. 
There is a hypothesis that SARS-CoV-2 may induce 
vasculopathy and coagulopathy. If the conditions occur 
in the brain, neuropsychiatry syndromes may manifest 
[2]. Excessive use of the internet during isolation also 
contributes to impaired mental function, mainly through 
the spread of unverified information regarding COVID-
19 [7], [6], [13]. Risk factors contributing to a mental 
health problem in COVID-19 patients are female gender, 
poor-self-related health, and the presence of relatives 
with COVID-19 [10]. Inadequacy of basic supplies and 
unclear information regarding the ongoing situation is 
considered as additional risk factors [13].
The symptoms of mental health 
disturbance
A wide range of mental health symptoms is 
observed, including anxiety, fear, loneliness, anger, 
encephalopathy, delirium, congenital impairment, mood 
swings, insomnia, suicide, psychosis, and general 
distress [1], [4], [6], [7], [11], [13]. Loss of significant ones 
may also result in persistent yearning and symptoms of 
reactive distress and social/identity disruption causing 
impairment in daily life. This condition is known as persistent 
complex bereavement disorder [14]. Mental health 
symptoms may manifest even in the absence of respiratory 
symptoms [12]. The impact of COVID-19 to mental health 
is always neglected in the acute phase of the disease. 
It is due to the critical course of COVID-19 which needs 
more attention and prompt management [3], [6]. Around 
35% patients with COVID-19 were reported to suffer from 
psychological distress [6]. Patients with COVID-19 had a 
higher rate of suffering from post-traumatic stress disorder 
(96.2%) and depression (29.2%) [10]. Other studies 
reported that 65% and 69% of COVID-19 patients who 
admitted to intensive care unit had delirium and agitation, 
respectively. Altered consciousness was reported in 21% 
of patients who deceased [4]. Approximately one-third 
of COVID-19 patients had neuropsychiatric syndromes 
such as encephalopathy and altered consciousness [8]. 
Patients with underlying mental problems have a higher 
risk in developing more severe symptoms; therefore, they 
should be treated with antipsychotic drugs together with 
standard COVID-19 treatment [6], [10].
The symptoms are not only present during the 
disease course but also after the patients recovered. 
Lower psychological well-being and higher anxiety 
score are observed in patients survived from COVID-
19 [10]. At discharge, 14.8% of patients had anxiety, 
while 14.9% and 32.2% had depression and post-
traumatic stress disorder, respectively [4]. Another 
study also reported mental health disorders such as 
post-traumatic stress disorder (54.5%), depression 
(39%), pain disorder (36.4%), panic disorder (32.5%), 
and obsessive-compulsive disorder (15.6%). This 
urges sustained follow-up for the mental health status 
of post-discharged patients [5].
Mental Health Problem in Health-care 
Personnel
Mental health problems are also found in 
health-care personnel in intense contact with COVID-19 
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patients, particularly general practitioners in emergency 
and staffs in intensive care units. They usually have fear, 
psychological distress, burnout, anxiety, depression, 
insomnia, somatization, post-traumatic stress disorder, 
and obsessive-compulsive disorders [5], [6], [10], [15]. 
The identified etiologies for a mental health problem in 
health-care personnel are lack of personal protective 
equipment, high working pressure, suboptimal training/
confidence when working in extreme circumstances, 
concerns of being infected or infecting their relatives, and 
lack of adequate support in the working environment [15].
Diagnosis of mental health problem
Before diagnosing COVID-19 patients with a 
mental disorder, we must exclude other possibilities 
such as metabolic disorders, hydration status, and 
medication effect. Brain magnetic resonance imaging 
(MRI) of COVID-19 patients with neuropsychiatric 
syndrome showed leptomeningeal enhancement and 
bilateral frontotemporal hypoperfusion. EEG finding 
is not specific, showing diffuse background slowing 
consistent with encephalopathy [8], [12]. Cerebrospinal 
fluid examination should be conducted in patients 
with seizure, encephalitis, and encephalomyelitis 
as coronaviruses may be detected [4]. After those 
possibilities have been excluded, we can assess one’s 
mental health status using several assessment tools. 
The Mental Health Quotient can be applied. It is safe 
enough since it is a web-based assessment tool. It 
is also fast, easy, and comprehensive toll based on 
Diagnostic and Statistical Manual of Mental Disorders 
(DSM)-5 [16]. However, DSM-5 is still being the most 
common and standard assessment tool for mental 
disorder used at present [17].
Treatment of mental health problems in 
COVID-19 patients
Literature regarding mental health problems 
due to COVID-19 and its management is scarce [3]. 
Psychological service should be maintained to prevent 
the effect of COVID-19 to patient’s mental health. 
Effective education and communication are important 
along with the management of stigma and discrimination 
toward patients [3], [13]. Constructive peer support 
significantly aids the management of mental health 
problems [7]. Other suggestions regarding calming skills, 
health and optimism maintenance, and social support 
system are also important in keeping the wellness of 
mental health [3], [12]. Cognitive-behavioral therapy 
(CBT) may be implemented in patients with mental 
health problems. It is suspected to be able to relieve 
the symptoms of mental disorder. During the pandemic, 
online CBT is one of the safest options [14]. Patients 
should have access to communication devices such as 
phone and tablet and also early ambulation. If behavioral 
management does not improve the symptoms, 
pharmacological management should be started [12]. 
Medications used to manage mental health problems in 
COVID-19 patients are antipsychotic agents (olanzapine 
and chlorpromazine), haloperidol, antidepressants, 
benzodiazepines, and amantadine [8], [11]. Melatonin, 
alpha-2 agonist, valproic acid, and dopamine agonists 
are also administered in patients with delirium. Vitamins 
are not a standard treatment for delirium. However, they 
have antioxidant and anti-inflammatory effects, which, 
more or less, may protect against neuropsychiatric 
symptoms [12]. Further study regarding the efficacy of 
each medication is mandatory [8], [11].
Conclusion
Mental health problems are frequently found 
in patients with COVID-19. The pathogenesis or 
mental health problems rely on direct invasion of virus, 
inflammation-induced demyelination, secondary to 
multiorgan failure, hypoxia, treatment-related, isolation, 
unconfirmed information, coagulopathy, vasculopathy, 
and uncertain outcome. Its symptoms vary widely, 
including delirium and anxiety. The symptoms are 
reported in both patients and health-care personnel. 
The auxiliary examinations for its diagnosis are not 
specific. Its management consists of psychological and 
medical management.
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